- Home
- BLFS vs GSBD Comparison
BLFS vs GSBD Comparison
Compare BLFS & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- GSBD
- Stock Information
- Founded
- BLFS 1987
- GSBD 2012
- Country
- BLFS United States
- GSBD United States
- Employees
- BLFS N/A
- GSBD N/A
- Industry
- BLFS Medical/Dental Instruments
- GSBD Finance: Consumer Services
- Sector
- BLFS Health Care
- GSBD Finance
- Exchange
- BLFS Nasdaq
- GSBD Nasdaq
- Market Cap
- BLFS 1.2B
- GSBD 1.1B
- IPO Year
- BLFS 1989
- GSBD N/A
- Fundamental
- Price
- BLFS $26.31
- GSBD $9.83
- Analyst Decision
- BLFS Strong Buy
- GSBD Sell
- Analyst Count
- BLFS 7
- GSBD 1
- Target Price
- BLFS $30.86
- GSBD $10.00
- AVG Volume (30 Days)
- BLFS 356.3K
- GSBD 831.6K
- Earning Date
- BLFS 11-11-2025
- GSBD 11-06-2025
- Dividend Yield
- BLFS N/A
- GSBD 12.85%
- EPS Growth
- BLFS N/A
- GSBD 52.30
- EPS
- BLFS N/A
- GSBD 1.24
- Revenue
- BLFS $93,468,000.00
- GSBD $402,124,000.00
- Revenue This Year
- BLFS $26.07
- GSBD N/A
- Revenue Next Year
- BLFS $16.86
- GSBD N/A
- P/E Ratio
- BLFS N/A
- GSBD $8.02
- Revenue Growth
- BLFS 68.16
- GSBD N/A
- 52 Week Low
- BLFS $19.10
- GSBD $9.51
- 52 Week High
- BLFS $29.55
- GSBD $13.80
- Technical
- Relative Strength Index (RSI)
- BLFS 57.56
- GSBD 20.32
- Support Level
- BLFS $24.33
- GSBD $9.91
- Resistance Level
- BLFS $27.42
- GSBD $10.20
- Average True Range (ATR)
- BLFS 0.89
- GSBD 0.20
- MACD
- BLFS 0.08
- GSBD -0.12
- Stochastic Oscillator
- BLFS 70.51
- GSBD 2.72
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About GSBD Goldman Sachs BDC Inc.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.